Both retatrutide and tirzepatide help control blood sugar and support weight loss, but they operate slightly differently: Tirzepatide : Activates two receptors ( GIP and GLP-1 ), boosting insulin release and promoting a feeling of fullness
The FDA-approved prescribing information for tirzepatide states that the medication can be administered at any time of day, with or without meals, providing significant flexibility for patients
Like all GLP-1 medications, oral semaglutide can cause side effects, primarily affecting the gastrointestinal system
When it comes to marketing materials, the Semaglutide program in BodySite has you covered
When Mounjaro binds to these receptors, it can occasionally cause these cells to grow slightly, potentially narrowing the small ducts that drain digestive enzymes
Proactive Health Management with Affinity Whole Health At Affinity Whole Health, we believe in a proactive approach to health management, especially when it comes to weight loss therapies like GLP-1 medications
